↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.3MSold on the market
1Companies
Oct 16, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202616:17 | Oct 15, 2026 | GILDGILEAD SCIENCES, INC. | Chief Financial Officer | S · Sell10b5-1 | $156.22 | −3,000 | 161,096 | -2% | −$469K | ||
| Sep 16, 202616:30 | Sep 15, 2026 | GILDGILEAD SCIENCES, INC. | Chief Financial Officer | S · Sell10b5-1 | $145.29 | −3,000 | 164,096 | -2% | −$436K | ||
| Sep 11, 202618:30 | Sep 10, 2026 | GILDGILEAD SCIENCES, INC. | Chief Financial Officer | M · Exercise | — | +2,797 | 168,443 | +2% | — | ||
| Sep 11, 202618:30 | Sep 10, 2026 | GILDGILEAD SCIENCES, INC. | Chief Financial Officer | F · Tax | $144.81 | −1,347 | 167,096 | -1% | $195K | ||
| Aug 18, 202619:06 | Aug 17, 2026 | GILDGILEAD SCIENCES, INC. | Chief Financial Officer | S · Sell10b5-1 | $138.36 | −3,000 | 165,646 | -2% | −$415K |